Secondary Logo

Journal Logo

June 2015 - Volume 38 - Issue 5
pp: 167-216

Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma

Müller, Nadja; Michen, Susanne; Tietze, Stefanie; More

Journal of Immunotherapy. 38(5):197-210, June 2015.